Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04651166
PHASE2

Effect of Prophylactic Tranexamic Acid on Bleeding Outcomes for Dilation and Evacuation

Sponsor: University of Hawaii

View on ClinicalTrials.gov

Summary

Prophylactic tranexamic acid has shown been shown to reduce maternal mortality from postpartum hemorrhage with no adverse effects, but has not been studied to reduce bleeding complications with dilation and evacuation (D\&E). We propose a randomized, double-blinded, placebo-controlled pilot study to determine whether routine use of intravenous (IV) tranexamic acid will decrease the need for interventions to control bleeding at the time of D\&E at 16 to 24 weeks gestation.

Key Details

Gender

FEMALE

Age Range

14 Years - Any

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2022-02-15

Completion Date

2023-07-27

Last Updated

2026-11-02

Healthy Volunteers

Yes

Interventions

DRUG

Tranexamic acid

1g tranexamic acid mixed in 100mL saline or lactated ringer

DRUG

Placebo

100mL saline or lactated ringers

Locations (1)

Queens Medical Center

Honolulu, Hawaii, United States